Limiting the role of antibiotics in children with adenotosilitis

Background In the past, group A beta-haemolytic streptococcus infection consequences were main goal of empirical antibiotic therapy sore throat. Antimicrobial stewardship is crucial due to threats posed by multi-resistant pathogens. The aim this study : was investigate possibility limiting role in children with adenotosilitis Methods: This hospital-based, randomised, prospective research involved 120 child who visited OPD both Pediatrics and Otorhinolaryngology departments, pesented adenotonsillitis enrolled . All cases met eligibility requirements randomly assigned two groups: 60 Group got systemic antibiotics. B received symptomatic treatment immune modulator, vit D 2000-5000 IU orally once daily. selected through 2 months from February 2022 April 2022. Age :2 years 9 years. younger less than 3 years, dysphagia expressed mothers as difficult swallowing crying during feeding drolling saliva. Results: Regarding baseline symptoms indicators after three days, there no discernible difference between groups B. However, six days therapy, considerably outperformed terms absent throat, dysphagia, tonsillar hypertrophy.